StockGuru Shines its Spotlight on Soligenix, Inc. (OTCBB: SNGX) Upon Announcement that Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD — September 16, 2011

StockGuru Shines its Spotlight on Soligenix, Inc. (OTCBB: SNGX) Upon Announcement that Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD — September 16, 2011

(Dallas, TX. – September 16, 2011) StockGuru Shines its Spotlight on Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company, announced that an independent Data Safety Monitoring Board (DSMB) recently completed a...